Novo Nordisk: NVO

The ethical drug company Novo Nordisk will report earnings on Wednesday, January 31. Analysts expect the company to report EPS of $0.67 on revenue of $8.7 billion.

This article is for paid members - please login or subscribe for access.

Share: